Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07105436 · ClinicalTrials.gov registry record
Thopaz for PALs Evaluation
A clinical trial of Persistent Air Leaks, sponsored by Kai Swenson.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT07105436 is a study of Persistent Air Leaks that is actively recruiting participants, run by Kai Swenson. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07105436, a study of Persistent Air Leaks, is actively recruiting participants, sponsored by Kai Swenson.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Persistent air leaks (PALs) are a common postoperative complication resulting from tears in the visceral pleura or peripheral lung resections. Although highly prevalent with significant consequences, traditional assessment methods lack the capability to objectively quantify air leaks, which further complicates management, results in inconsistent decision making, and prolongs hospital stays. By incorporating the Thopaz+ system, the investigators can introduce a reliable approach to objectively quantify air leaks, potentially improving clinical outcomes. The purpose of this protocol is to perform a pilot prospective controlled clinical trial to evaluate the utility of incorporating the Thopaz+ system and its volume quantification ability in evaluating patients with persistent air leaks (PALs) to guide treatment decisions, specifically endobronchial valves (EBVs). In the targeted cohort, the Thopaz+ will be connected to the chest tube and the data collected will be combined with that of serial balloon occlusion testing with a Fogarty balloon to accurately localize the air leak source, and subsequently consider the correct placement of EBVs. The investigators will thereby determine whether this experimental strategy will yield a more accurate and objective assessment of air leaks, facilitating timely interventions and improved patient outcomes.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Persistent air leak quantification
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-01-01 |
| Est. Completion | 2026-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07105436
The ClinicalTrials.gov registry entry for NCT07105436 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kai Swenson, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Persistent Air Leaks appearing as the primary indexed condition, and to 1 intervention - of which Persistent air leak quantification is the first listed.
NCT07105436 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07105436 about?
NCT07105436 is a clinical study titled "Thopaz for PALs Evaluation". Persistent air leaks (PALs) are a common postoperative complication resulting from tears in the visceral pleura or peripheral lung resections. Although highly prevalent with significant consequences, traditional assessment methods lack the capability to objectively quantify air leaks, which further ...
What is the current status of trial NCT07105436?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2026-01-01. Estimated completion is 2026-09.
What conditions does trial NCT07105436 study?
This clinical trial studies the following conditions: Persistent Air Leaks.
What interventions are being tested in trial NCT07105436?
The interventions under investigation include: Persistent air leak quantification (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07105436?
This trial is sponsored by Kai Swenson, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07105436 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Persistent Air Leaks
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.